These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22006002)

  • 1. NDM-1-producing Klebsiella pneumoniae in Mauritius.
    Poirel L; Lascols C; Bernabeu S; Nordmann P
    Antimicrob Agents Chemother; 2012 Jan; 56(1):598-9. PubMed ID: 22006002
    [No Abstract]   [Full Text] [Related]  

  • 2. Extremely drug-resistant NDM-9-producing ST147
    Falcone M; Giordano C; Barnini S; Tiseo G; Leonildi A; Malacarne P; Menichetti F; Carattoli A
    Euro Surveill; 2020 Dec; 25(48):. PubMed ID: 33272354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.
    Ku YH; Chen CC; Lee MF; Chuang YC; Tang HJ; Yu WL
    J Microbiol Immunol Infect; 2017 Dec; 50(6):931-939. PubMed ID: 28716360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First report of NDM-1-producing Klebsiella pneumoniae imported from Africa to Italy: Evidence of the need for continuous surveillance.
    Principe L; Mauri C; Conte V; Pini B; Giani T; Rossolini GM; Luzzaro F
    J Glob Antimicrob Resist; 2017 Mar; 8():23-27. PubMed ID: 27939808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli.
    Docobo-Pérez F; Nordmann P; Domínguez-Herrera J; López-Rojas R; Smani Y; Poirel L; Pachón J
    Int J Antimicrob Agents; 2012 Mar; 39(3):251-4. PubMed ID: 22154856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-resistance to colistin and tigecycline by disrupting mgrB and ramR with IS insertions in a canine Klebsiella pneumoniae ST37 isolate producing SHV-12, DHA-1 and FosA3.
    Taniguchi Y; Maeyama Y; Ohsaki Y; Hayashi W; Osaka S; Koide S; Tamai K; Nagano Y; Arakawa Y; Nagano N
    Int J Antimicrob Agents; 2017 Nov; 50(5):697-698. PubMed ID: 28943368
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin.
    Humphries RM; Kelesidis T; Dien Bard J; Ward KW; Bhattacharya D; Lewinski MA
    J Med Microbiol; 2010 Nov; 59(Pt 11):1383-1386. PubMed ID: 20688947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin.
    Endimiani A; Patel G; Hujer KM; Swaminathan M; Perez F; Rice LB; Jacobs MR; Bonomo RA
    Antimicrob Agents Chemother; 2010 Jan; 54(1):526-9. PubMed ID: 19901089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea.
    Kim SY; Shin J; Shin SY; Ko KS
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):486-90. PubMed ID: 23688521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiclonal Expansion of Klebsiella pneumoniae Isolates Producing NDM-1 in Rio de Janeiro, Brazil.
    Aires CA; Pereira PS; de Araujo CF; Chagas TP; Oliveira JC; Buonora SN; Albano RM; Carvalho-Assef AP; Asensi MD
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal administration of colistin for meningitis due to New Delhi metallo-β-lactamase 1(NDM-1)-producing Klebsiella pneumoniae.
    Inamasu J; Ishikawa K; Oheda M; Nakae S; Hirose Y; Yoshida S
    J Infect Chemother; 2016 Mar; 22(3):184-6. PubMed ID: 26683242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
    Spanu T; De Angelis G; Cipriani M; Pedruzzi B; D'Inzeo T; Cataldo MA; Sganga G; Tacconelli E
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4516-8. PubMed ID: 22644031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel NDM-9 metallo-β-lactamase identified from a ST107 Klebsiella pneumoniae strain isolated in China.
    Wang X; Li H; Zhao C; Chen H; Liu J; Wang Z; Wang Q; Zhang Y; He W; Zhang F; Wang H
    Int J Antimicrob Agents; 2014 Jul; 44(1):90-1. PubMed ID: 24913967
    [No Abstract]   [Full Text] [Related]  

  • 14. Emergence of tigecycline- and carbapenem-nonsusceptible Klebsiella pneumoniae ST11 clone in patients without exposure to tigecycline.
    Sheng ZK; Wang W; Guo Q; Xu X; Wang M; Yang Y; Wang M
    J Microbiol Immunol Infect; 2016 Dec; 49(6):962-968. PubMed ID: 26692183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital Outbreak of a Colistin-Resistant, NDM-1- and OXA-48-Producing Klebsiella pneumoniae: High Mortality from Pandrug Resistance.
    Guducuoglu H; Gursoy NC; Yakupogullari Y; Parlak M; Karasin G; Sunnetcioglu M; Otlu B
    Microb Drug Resist; 2018 Sep; 24(7):966-972. PubMed ID: 29265963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology and risk factors for colistin- or tigecycline-resistant carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients during a 7-year period.
    Papadimitriou-Olivgeris M; Bartzavali C; Spyropoulou A; Lambropoulou A; Sioulas N; Vamvakopoulou S; Karpetas G; Spiliopoulou I; Vrettos T; Anastassiou ED; Fligou F; Christofidou M; Marangos M
    Diagn Microbiol Infect Dis; 2018 Nov; 92(3):235-240. PubMed ID: 30076041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.
    Rodríguez-Avial C; Rodríguez-Avial I; Merino P; Picazo JJ
    Clin Microbiol Infect; 2012 Jan; 18(1):61-6. PubMed ID: 21722259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases.
    Conejo MC; Hernández JR; Pascual A
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):343-5. PubMed ID: 18339509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis.
    Stone NR; Woodford N; Livermore DM; Howard J; Pike R; Mushtaq S; Perry C; Hopkins S
    J Antimicrob Chemother; 2011 Nov; 66(11):2677-8. PubMed ID: 21846669
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections in a Chinese Children's Hospital: Predominance of New Delhi Metallo-β-Lactamase-1.
    Dong F; Zhang Y; Yao K; Lu J; Guo L; Lyu S; Yang Y; Wang Y; Zheng H; Song W; Liu G
    Microb Drug Resist; 2018 Mar; 24(2):154-160. PubMed ID: 28594635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.